Fin Cascade
Get Android appGet iOS app

Prices as of 9 Oct 2026 close · Not investment advice

GSP Crop Science Limited

NSE: GSPCROPPesticides & Agrochemicals

Share price

₹482.90

-1.87% close of 9 Oct 2026

Market cap ₹2,270 CrP/E 21.7

Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 8 Oct 2026, the close above is 9 Oct 2026.

Business score

How strong the business is, in one number. The parts behind it are in Pro.

54

out of 100 · worked out 9 Oct 2026

How the business score works

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹2,270 Cr

P/E ratio

21.7

P/B ratio

2.9

ROCE

18.9%

ROE

16.5%

Dividend yield

0.2%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 9 Oct 2026 close52-week high ₹643.1552-week low ₹337.90

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Fewer than three years of filings — too early to judge growth.

Whether it grew faster than its sector

It grew 6.9% a year against a sector median of 10.2% — 3.2 percentage points slower.

Room to re-rate, or risk of de-rating

Too little price history yet to compare it with its own past.

Whether growth justifies the valuation

Priced at 0.3 times its growth rate, on earnings growth of 67%.

Profit growthPrice per ₹1 profitPer 1% growth
GSP Crop Science Limited — this one67%/yr21.7×₹0.32
UPL Limited-21%/yr20.9×—
PI Industries Limited-1%/yr29.4×—
Sumitomo Chemical India Limited2%/yr36.4×₹18.2
Bayer Cropscience Limited1%/yr21.4×₹21.4
Sharda Cropchem Limited26%/yr10.4×₹0.40

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Pesticides & Agrochemicals), it ranks 6 of 23 on returns, 15 of 23 on growth, 11 of 23 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

A narrow advantage: it earns 18.9% on capital, ahead of 74% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Yes — Over the last five years it made ₹364 crore of cash from the business, spent ₹259 crore on plant and equipment, and returned ₹2 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 7 years, about 131 arrived as cash (before interest, which is why it can exceed the profit).

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

8 of 10 checks clear · 80%

How the profit check works

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Sales almost flat at ₹386 crore while profit rose 16% to ₹26 crore

Announced 11 Aug 2026 · Consolidated · Unaudited

Revenue

₹386 Cr

Revenue vs last quarter

-4.0%

Net profit

₹26 Cr

Profit vs last quarter

+32.0%

Net margin

6.8%

EPS

₹5.67

Earnings call transcript · 12 Aug 2026

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹2,270 Cr
Prev close
₹482.90
52w High
₹668
52w Low
₹328
Enterprise value
₹2,347 Cr
Beta
1.0
Price CAGR 1y
—
Price CAGR 3y
—
Price CAGR 5y
—
Price CAGR 10y
—

Ratios

Return on assets
6.1%
PEG ratio
0.3
P/E ratio
21.7
P/B ratio
2.9
EV / EBITDA
12.7
Industry P/E
20.1
ROCE
18.9%
ROCE 5y average
16.6%
ROE
16.5%
Debt / Equity
0.3
Interest coverage
4.4
Dividend yield
0.2%
ROE 3y average
18.0%
ROE last year
17.0%

Annual P&L

Annual revenue
₹1,517 Cr
Annual profit
₹95 Cr
Operating margin
12.0%
Net profit margin
6.3%
EBITDA margin
12.2%
Sales growth 3y
8.0%
Sales growth 5y
7.1%
Profit growth 3y
67.0%
Profit growth 5y
8.0%
EPS
₹21.1
Sales growth TTM
18.0%
Profit growth TTM
21.0%
Dividend payout
5.0%

Quarter P&L

Sales latest quarter
₹386 Cr
Profit latest quarter
₹26 Cr
YoY quarterly sales growth
2.4%
YoY quarterly profit growth
13.0%
OPM latest quarter
11.0%

Balance Sheet

Book Value
₹164
Face Value
₹10.0
Total debt
₹262 Cr
Total cash
₹172 Cr
Borrowings
₹262 Cr
Reserves / Equity
15.4

Cash Flow

Operating cash flow
₹59 Cr
Free cash flow
-₹17 Cr
FCF yield
-2.4%
Net cash flow
₹137 Cr

Shareholding

Promoter holding
71.7%
FII holding
9.2%
DII holding
0.4%
Public holding
18.7%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
UPL495.0021.141,7731.21-73.092.610,181.010.510.1
P I Industries2,210.0031.033,5300.68244.2-39.01,702.3-10.415.0
Sumitomo Chemi.421.9536.921,0610.31216.59.31,054.10.623.5
Bayer Crop Sci.3,491.5021.415,6924.30321.615.41,835.0-4.229.1
Sharda Cropchem742.0510.76,6952.0288.0-38.31,073.89.030.3
Dhanuka Agritech891.8014.83,9760.2236.3-34.6461.9-12.623.8
Rallis India200.0317.03,8901.50125.030.01,022.06.814.1
GSP Crop Science482.8021.52,2460.2126.412.3386.02.418.9
Median316.2021.11,6520.1724.616.8383.7-2.315.4

Competes with: Bayer Cropscience Limited, Dhanuka Agritech Limited, NACL Industries Limited, PI Industries Limited, Rallis India Limited, Sharda Cropchem Limited, Sumitomo Chemical India Limited, UPL Limited

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Consolidated · to 30 Jun 2026
Line itemSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales703276308377467270402386
Expenses273268335374257366343
Material Cost223216295
Change in Inventories-6143-54
Purchases of Stock-in-Trade2.699.372.66
Employee Cost272732
Other Expenses657168
Operating Profit3404293133643
OPM %150.981311204.929.0211
Other Income1831-398
Exceptional items (within Other Income)-4.51-0.040
Interest888910107
Depreciation6777889
Profit before tax-11323078-82735
Tax %-43322425-222825
Net Profit-6222358-62026
EPS in Rs-1.495.816.0215-1.384.405.67
Diluted EPS in Rs-1.385.095.67

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Consolidated · to 31 Mar 2026
Line itemMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales9031,0771,1911,2031,1521,2871,5171,526
Expenses8329491,0621,1251,0281,1371,3321,341
Material Cost934
Change in Inventories11
Purchases of Stock-in-Trade14
Employee Cost107
Other Expenses266
Operating Profit7212912979124150185185
OPM %81211711121212
Other Income4111461214915
Exceptional items (within Other Income)-4.56
Interest2518243734313735
Depreciation1818202120233032
Profit before tax341031002782110127133
Tax %36342521262626
Net Profit2168762261829599
EPS in Rs7223025678236212124
Diluted EPS in Rs25
Dividend Payout %10443445

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
—
5 years
7%
3 years
8%
TTM
18%

Compounded profit growth

10 years
—
5 years
8%
3 years
67%
TTM
21%

Return on equity

10 years
—
5 years
15%
3 years
18%
Last year
17%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Consolidated
Line itemMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital29292927263947
Reserves302366439336344411725
Borrowings169139320324235297262
Other Liabilities242383466444374491513
Minority Interest-1.38
Total Liabilities7429181,2551,1329801,2381,547
Fixed Assets159161166169177214228
CWIP791116515067
Investments202381216
Other Assets5737471,0769457459611,236
Total Assets7429181,2551,1329801,2381,547

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Consolidated
Line itemMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity80114-441042073859
Cash from Investing Activity-24-19-42-47-19-80-74
Cash from Financing Activity-59-50157-159-17830152
Net Cash Flow-34571-10210-12137
Free Cash Flow6491-9370179-34-17

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Consolidated
Line itemMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days11399125126103112133
Inventory Days119153182155111189146
Days Payable113162165156114176158
Cash Conversion Cycle1209014212599126121
Working Capital Days54517256395068
ROCE %23188172119

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Consolidated · to 30 Jun 2026
Line itemMar 2026Jun 2026
Promoters7272
FIIs129.19
DIIs2.960.37
Public1419
No. of Shareholders8,4447,876

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year +35.6% (₹356.25 → ₹482.90)Brick size ₹22.58 (fixed)Bricks 20
₹400₹600₹483May '26Jul '26Sep '26
Price moved up one brickPrice moved down one brickLast close ₹482.90 on 9 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

exports as % of revenue

10.00pct

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

own market share %

3.00pct

2026-06-30

net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash

77.81inr_cr

2026-03-31

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

10.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

News

News and filings about GSP Crop Science Limited. Open one to see why it matters.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Competes with

Uses as raw material

  • Diethyl Thio Phosphoryl Chloride
  • Triazole
  • Trichloro Acetyl Chloride (TCAC)
  • agrochemical technical intermediates
  • imported technicals (China-sourced)

Depends on the price of

  • fuel

Sells to

  • Agrico Organics Limited · crop-protection technicals / formulations (B2B)
  • Bharat Rasayan Limited · crop-protection technicals / formulations (B2B)
  • Dharmaj Crop Guard Limited · crop-protection technicals / formulations (B2B)
  • Indogulf Cropsciences Limited · crop-protection technicals / formulations (B2B)
  • SML Limited · crop-protection technicals / formulations (B2B)
  • Willowood Chemicals Limited · crop-protection technicals / formulations (B2B)

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Chemicals
Industry
Pesticides & Agrochemicals
Classification
Chemicals › Pesticides & Agrochemicals
ISIN
INE713R01022

Plants

  • GSP Kathwada Facility
  • GSP Nandesari Facility
  • GSP Odhav Facility
  • GSP Samba Facility
  • GSP Saykha Facility

News impact

Big market events that reach GSP Crop Science Limited, and how the effect spreads.

23 Sept, 07:38 IST · Market event · medium impact

India starts anti-dumping probe into Chinese Glycine imports

India is probing cheap Chinese glycine imports, which could help home chemical makers later but may raise costs for food, drug and farm buyers if an import tax follows.

Chemicals

Who it hits first

  • India's trade investigator (DGTR, the body that checks unfair imports) opened a probe into cheap glycine, a simple chemical used in food, drugs and farm sprays, arriving from China.
  • If the probe finds harm to local makers, India can add an import tax (anti-dumping duty) that makes Chinese glycine costlier and helps home producers sell more.
  • No listed glycine maker is named in the evidence, so any stock lift today is hope of future protection, while buyers of glycine could later pay more.

Who may gain

  • Indian glycine and nearby specialty makers, if a duty lifts local prices (no single listed maker confirmed in the pack)
  • Farm-chemical sellers such as PI Industries and GSP Crop, if protection spreads to agro inputs

Along the supply chain

Downstream

Indian food, drug and farm-spray makers that buy glycine could face higher input costs if cheap Chinese supply is taxed.

Upstream

Chinese glycine exporters face the probe; if a duty follows, their shipments to India shrink.

Where demand moves

Business

No extra orders yet — the probe only starts the case; real business gain comes months later if a duty curbs Chinese supply and buyers switch to home makers.

Capital

No fresh funds flow; investors may bid up chemical shares on protection hopes, but cash gains arrive only if duties lift prices and profits.

How it spreads across sectors

Chemicals

Small positive mood for home makers on protection hopes; real gains only if a duty lands.

Pharma

Mild cost worry since glycine feeds drugs; dearer supply would squeeze pill makers later.

Textiles

Negligible near-term link; fibre makers watch only for broader China-duty mood.

A pattern seen before

Cascade chain

  • DGTR probes Chinese glycine dumping → possible import duty
  • Duty curbs cheap imports → domestic glycine prices firm
  • Chemical makers gain share → pharma and textile buyers face higher costs

Pattern name

China Cascade

Patterns

  • China Cascade

Sectors queried

  • Pharma
  • Textiles

When it plays out

Immediate

1–7 days: chemical shares drift on protection hopes with no order change.

Medium term

1–6 months: probe findings decide any duty; only then do prices, orders and margins move.

Short term

1–4 weeks: filings and hearing news set expectations; buyers watch for price hints.

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

11 Sep 2026unspecified₹1

Bulk & block deals

DateWhoBought / soldSharesPrice
6 Jul 2026SETU SECURITIES PRIVATE LIMITEDBUY4,05,000₹402.53

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.